Next generation sequencing (NGS) Market by Product & Services (Pre-Sequencing Products & Service, Sequencing Services, Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing), Application (Diagnostics, Drug Discovery), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers) - Analysis & Forecast 2019-2030

Report ID : 3  |  Published Date : Jan 2019  |  Pages : 150  |  Region : Global  |  Report Code : MD-03





Next generation sequencing (NGS) Market Overview and Introduction

Global Next generation sequencing (NGS) Market is estimated to be over US$ 4.0 Billion in 2018. It is anticipated to grow at a 18.8% CAGR from 2019 to 2030.

Next generation sequencing (NGS) also known as high-throughput sequencing technique that enables scientists and researchers to sequence and assemble short DNA sequences. Next generation sequencing technologies has brought significant changes in the sequencing process by providing high throughput, speed, flexibility and reduced sequencing cost. NGS can generate hundreds of nucleotide sequence data in a single sequencing run when programmed. The NGS technology has grown rapidly owing to its growing adoption in clinical applications in whole genomes or targeted genomes sequencing. Also the cost of sequencing has reduced leading to usage of next generation sequencing in variety of clinical applications. The NGS technology has clinical applications in field like cancer, inherited genetic disorders, identification of infectious diseases and cancer related disorders.

Next generation sequencing (NGS) Market

Next generation sequencing (NGS) Market by Product & Services, Technology, Application, End-Users and Geography

The market for next generation sequencing can be segmented based on product & services, technology, application, end-users and geography.  The product segment can be categorized as Pre-Sequencing Products & Services, NGS Consumables, Platforms, & Services for Platforms, Sequencing Services and NGS Data Analysis, Storage, and Management (Bioinformatics). On the basis of technology the market is subdivided into sequencing by synthesis, ion semiconductor sequencing, single molecule real time sequencing, Nanopore Sequencing, and Other Sequencing Technologies. Based on application the market can be categorized into drug discovery, diagnostics and other applications. Based on the end user segment the market can be segmented as hospitals & clinics, Academic Institutes & Research Centers and pharmaceutical and biotechnology companies and other end users. 

Next generation sequencing (NGS) Market by Regions 

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (Latin America (LATAM), and Middle East and Africa (MENA).  North America accounted for the largest market share of the market followed by Europe.  However, during the forecast period Asia-Pacific region is anticipated to record highest growth owing to wide penetration of the technology and technological advancement in NSG, increasing focus on drug discovery initiatives by healthcare and biopharmaceutical companies, investment by pharmaceutical and biotechnology companies in drug discovery are some of the key factors expected to drive the growth of next generation sequencing market.

Next generation sequencing (NGS) Market Prominent Players 

Some of the major players operating in the global NGS market are Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.   Market Classification
      2.   Geographic Scope
      3.   Years Considered for the Study
        1. Historical Years – 2016 & 2017
        2. Base Year – 2018
        3. Forecasted Years – 2019 to 2030
    3. Currency Used for the Study
    4. Report Beneficiary List
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.   Bottoms Up Approach
      2.   Top Down Approach
    5. Data Validation and Triangulation
      1.   Market Forecasting Model
      2.   Limitations of the Study
      3.   Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Technological Advancement
    2. Cost Assessment: Sequencing & NGS Instruments
    3. Application Horizon Assessment
    4.   Initiatives Assessment: Government & Private Bodies
    5. Regulatory & Reimbursement Scenario Snapshot
  6. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET - ANALYSIS & FORECAST, BY PRODUCT & SERVICES
    1. Introduction & Definition
    2. Pre-Sequencing Products & Services
      1. Sample Preparation
        1.     DNA Fragmentation, End Repair, A-Tailing, and Size Selection
        2.     Library Preparation & Target Enrichment
        3.     Quality Control
    3. NGS Consumables, Platforms, & Services for Platforms 
      1. NGS Consumables
      2. NGS Platforms
        1.    Illumina
        2.    Thermo Fisher Scientific
        3.    Pacific Biosciences
        4.    Oxford Nanopore Technologies
        5.    Other Next-Generation Sequencing Platforms
      3. Services for NGS Platforms
    4. Sequencing Services 
      1. Exome & Targeted Re-Sequencing and Custom Panels
      2. RNA-Seq
      3. Whole-Genome Sequencing & De Novo Sequencing
      4. Other Sequencing Services
    5. NGS Data Analysis, Storage, and Management (Bioinformatics) 
      1. NGS Data Analysis Software & Workbenches
      2. NGS Data Analysis Services
      3. NGS Storage, Management, and Cloud Computing Solutions
        1.    Interference Screws
        2.    Sutures
        3.    Others
  7. GLOBAL NEXT-GENERATION SEQUENCING MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
    1. Introduction 
    2. Sequencing By Synthesis 
    3. Ion Semiconductor Sequencing 
    4. Single-Molecule Real-Time Sequencing 
    5. Nanopore Sequencing 
    6. Other Sequencing Technologies
  8. GLOBAL NEXT-GENERATION SEQUENCING MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Introduction 
    2. Diagnostics 
      1. Cancer Diagnostics
      2. Infectious Disease Diagnostics
      3. Reproductive Health Diagnostics
      4. Other Diagnostic Applications
    3. Drug Discovery 
    4. Other Applications
  9. GLOBAL NEXT-GENERATION SEQUENCING MARKET - ANALYSIS & FORECAST, BY END USER
    1. Introduction 
    2. Academic Institutes & Research Centers 
    3. Hospitals & Clinics 
    4. Pharmaceutical & Biotechnology Companies 
    5. Other End User
  10. GLOBAL NEXT-GENERATION SEQUENCING MARKET - ANALYSIS & FORECAST, BY REGION
    1.     North America Next-Generation Sequencing (NGS) Market
      1.   North America Next-Generation Sequencing (NGS) Market, By Country
        1.  US
        2.  Canada
      2. North America Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Product & Services
      3. North America Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Technology
      4. North America Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Application
      5. North America Next-Generation Sequencing (NGS) Market Analysis & Forecast, By End User
    2. Europe Next-Generation Sequencing (NGS) Market
      1. Europe Next-Generation Sequencing (NGS) Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Product & Services
      3. Europe Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Technology
      4. Europe Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Application
      5. Europe Next-Generation Sequencing (NGS) Market Analysis & Forecast, By End User
    3. Asia Pacific Next-Generation Sequencing (NGS) Market
      1. Asia Pacific Next-Generation Sequencing (NGS) Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Product  &  Services
      3. Asia Pacific Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Technology
      4. Asia Pacific Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Application
      5. Asia Pacific Next-Generation Sequencing (NGS) Market Analysis & Forecast, By End User
    4.    Rest of the World (ROW) Next-Generation Sequencing (NGS) Market
      1. Rest of the World Next-Generation Sequencing (NGS) Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Next-Generation Sequencing (NGS) Market Analysis & Forecast, By  Product & Services
      3. Rest of the World Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Technology
      4. Rest of the World Next-Generation Sequencing (NGS) Market Analysis & Forecast, By Application
      5. Rest of the World Next-Generation Sequencing (NGS) Market Analysis & Forecast, By End User
  11. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  12. COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1.    10x Genomics
    2.    Agilent Technologies, Inc.
    3.    Beckman Coulter (A Subsidiary of Danaher)
    4.    Becton, Dickinson and Company
    5.    BGI
    6.    Eurofins Scientific
    7.    F. Hoffmann-La Roche AG
    8.    Genewiz
    9.     Illumina, Inc.
    10. Macrogen, Inc  (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
  13. APPENDIX
    1. Questionnaire
    2. Primary Interviews Transcripts
    3.    Customization Options
    4. Profile of the Author